article thumbnail

Calibre Scientific Expands European Presence and Chromatography Offering With AIT France Acquisition

The Pharma Data

25, 2021 (GLOBE NEWSWIRE) — Calibre Scientific is pleased to announce the acquisition of AIT France (“AIT”), a manufacturer and distributor of innovative consumables for analytical chemistry and chromatography. Headquartered in Paris, France, AIT supplies public and private researchers and pharmaceutical laboratories.

article thumbnail

Women in Stem with Dr Mrunal Jaywant

Drug Target Review

I started working as a trainee immediately after submitting my PhD thesis in Analytical chemistry to Pune university in India but initially felt immense pressure to prove myself, not only because I was a woman but also because there were very few PhD staff, in general. I am currently leading USP’s Nitrosamine workstream, globally.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Embarking on a Career in Drug Development

Alta Sciences

A: Drug development uses a lot of the same skills as forensic science—the analytical chemistry, the problem-solving—with just a different application. Learning about how drugs are developed and tested, and learning about the science behind the pharmaceutical industry, has been amazing. Q: What drew you to drug development?

article thumbnail

Beyond the Lab: Commercial Careers in Life Science

Elrig

I have a year long masters project based within a CRO’s analytical chemistry innovations department initially working in the lab. What scope is there for pursuing commercial life science roles without a PhD, but with an MSc that has aspects of commercial development in the pharmaceutical industry?

Science 40
article thumbnail

BioSpace Movers & Shakers, Nov. 6

The Pharma Data

X4 Pharmaceuticals – Art Taveras was named CSO of Cambridge, Mass.-based Prior to that, Taveras was vice president of Small Molecule Drug Discovery and CMC Development at Biogen Idec, and Alantos Pharmaceuticals, which was acquired by Amgen in 2007. Venugopal most recently served as executive director at Intercept Pharmaceuticals.